HP-505
HP-505是一種有機化合物,化學式為C18H19NO。它是由赫美羅製藥公司研發的三重再攝取抑制劑。[1]HP-505在小鼠試驗中發現是丁苯那嗪誘導的上瞼下垂的有效抑制劑,這表明它可能具有抗抑鬱活性。[2]
識別資訊 | |
---|---|
| |
CAS號 | 59142-94-8 |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C18H19NO |
摩爾質量 | 265.36 g·mol−1 |
3D模型(JSmol) | |
| |
|
藥理學
編輯5-HT | NE | DA | NE:5-HT | DA:5-HT |
---|---|---|---|---|
0.19 ± 0.04 | 0.34 ± 0.1 | 0.66 ± 0.15 | 1.8 | 3.5 |
化學性質
編輯HP-505在碳酸氫鈉存在下,可以和2-氯-4-硝基吡啶-1-氧化物反應,得到N-(1-氧化-4-硝基吡啶-2-基)-HP-505。[3]
參考文獻
編輯- ^ 1.0 1.1 Meyerson, Laurence R; Ong, Helen H; Martin, Lawrence L; Ellis, Daniel B. Effect of antidepressant agents on β-adrenergic receptor and neurotransmitter regulatory systems. Pharmacology Biochemistry and Behavior. June 1980, 12 (6): 943–948. PMID 6105676. S2CID 45400599. doi:10.1016/0091-3057(80)90457-8.
- ^ Klioze, SS; Bauer, VJ; Geyer HM, 3rd. Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 2. Compounds containing a heteroatom attached to nitrogen.. Journal of Medicinal Chemistry. April 1977, 20 (4): 610–2. PMID 850252. doi:10.1021/jm00214a039.
- ^ Allerton, Charlotte Moira Norfor; Owen, Dafydd Rhys; Ryckmans, Thomas; Stammen, Blanda Luzia Christa. Spiropiperidine derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as delta opioid receptor agonists. 2007 WO 2007057775 A1.